Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
08/07/2012 | US8236525 Reduced phosphotransferase system activity in bacteria |
08/07/2012 | US8236524 Modified microorganism |
08/07/2012 | US8236523 Camp reporters and high throughput assays |
08/07/2012 | US8236510 Protein showing enhanced expression in cancer cells |
08/07/2012 | US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use |
08/07/2012 | US8236487 Tumor specific oligosaccharide sequences and use thereof |
08/07/2012 | US8236324 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection |
08/07/2012 | US8236307 Humanized anti-FGF19 antagonists and methods using same |
08/07/2012 | CA2525961C Targeted biocides |
08/07/2012 | CA2457652C Soluble t cell receptor |
08/07/2012 | CA2447367C Diagnosis and treatment of malignant neoplasms |
08/07/2012 | CA2445421C Von willebrand factor (vwf)-cleaving protease |
08/07/2012 | CA2429384C Concatameric immunoadhesion |
08/07/2012 | CA2317721C Novel steroid-activated nuclear receptors and uses therefor |
08/07/2012 | CA2146895C Ctla4/cd28ig hybrid fusion proteins |
08/02/2012 | WO2012103496A2 Expression of soluble viral fusion glycoproteins in mammalian cells |
08/02/2012 | WO2012103345A1 Compositions containing glycosylated antibodies and uses thereof |
08/02/2012 | WO2012103341A1 Treatment of advanced solid stage tumors using anti-erbb3 antibodies |
08/02/2012 | WO2012103260A2 High-throughput methods to produce, validate and characterize mmabs |
08/02/2012 | WO2012103165A2 Anti-kit antibodies and uses thereof |
08/02/2012 | WO2012102171A1 Yeast for transformation and process for producing protein |
08/02/2012 | WO2012071422A3 Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins |
08/02/2012 | WO2011137245A3 Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use |
08/02/2012 | WO2010110838A3 Antibody constant domain regions and uses thereof |
08/02/2012 | US20120198575 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
08/02/2012 | US20120197003 Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on enzyme peptide inhibitors and methods for obtaining them |
08/02/2012 | US20120196803 Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
08/02/2012 | US20120196797 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
08/02/2012 | US20120196790 Cyclic depsipeptides |
08/02/2012 | US20120196372 Methods for Reducing Gluconoylation of Proteins |
08/02/2012 | US20120196328 Fusion protein mixture for inducing human pluripotent stem cell and preparation method there of |
08/02/2012 | US20120196327 Process for production of protein |
08/02/2012 | US20120196326 Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture |
08/02/2012 | US20120196325 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
08/02/2012 | US20120196324 Method for Producing an Antifungal Peptide in a Filamentous Fungal Host Cell |
08/02/2012 | US20120196323 Fermentation Process |
08/02/2012 | US20120196322 Protein production |
08/02/2012 | US20120195962 Multiepitope Vaccine for Her2/Neu-Associated Cancers |
08/02/2012 | US20120195925 Vaccines with increased immunogenicity and methods for obtaining them |
08/02/2012 | US20120195912 Cripto Blocking Antibodies and Uses Thereof |
08/02/2012 | US20120195909 Antibodies against a proliferating inducing ligand (april) |
08/02/2012 | US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES |
08/02/2012 | US20120195903 Method for the production of antibodies |
08/02/2012 | US20120195900 Tri-variable domain binding proteins and uses thereof |
08/02/2012 | US20120195897 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
08/02/2012 | US20120195895 Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use Thereof |
08/02/2012 | US20120195879 Carrier immunoglobulins and uses thereof |
08/02/2012 | CA2825722A1 Expression of soluble viral fusion glycoproteins in mammalian cells |
08/02/2012 | CA2824927A1 Compositions containing glycosylated antibodies and uses thereof |
08/01/2012 | EP2481803A1 Molecules of nucleic acids coding a dextran-saccharase catalysing the synthesis of dextran having alpha-1,2 osidic branching |
08/01/2012 | EP2481798A1 Aspergillus non-inherited genetic variant having enhanced protease activity, and a production method for a natural flavour enhancer employing the same |
08/01/2012 | EP2481792A1 High yield antibiotics producing fungus strain, preparation method and use thereof |
08/01/2012 | EP2481287A1 Human skin equivalents expressing exogenous polypeptides |
08/01/2012 | EP2480671A1 Process for producing molecules containing specialized glycan structures |
08/01/2012 | EP2480665A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
08/01/2012 | EP2480661A1 Bacterial host strain |
08/01/2012 | EP2480245A1 A novel method for the production of a antimicrobial peptide |
08/01/2012 | EP2132319B1 Method for producing an antifungal peptide in a filamentous fungal host cell |
08/01/2012 | EP1964916B1 Multi-purpose acylation catalayst and use thereof |
08/01/2012 | EP1728864B1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
08/01/2012 | EP1713825B1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
08/01/2012 | EP1328653B1 Highly expressible genes |
08/01/2012 | EP1133310B1 Artery- and vein-specific proteins and uses therefor |
08/01/2012 | EP0574402B2 Expression of pace in host cells and methods of use thereof |
08/01/2012 | CN102625848A Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
08/01/2012 | CN102625810A A fungal protease and use thereof |
08/01/2012 | CN102618614A Method for preparing urechis unicinctus glycosaminoglycan and antibacterial peptide simultaneously |
08/01/2012 | CN102618613A Method for screening protein biological markers related to hepatic stellate cell activation and hepatic fibrosis |
08/01/2012 | CN102618612A Preparation method for black-bone chicken peptide for chemotherapy, attenuation and synergia and application of black-bone chicken peptide |
08/01/2012 | CN102618611A Method for preparing corn oligopeptide by using membrane integration technology |
08/01/2012 | CN102618610A Preparation method of sericin compound amino acid |
08/01/2012 | CN102618609A Method for comprehensively utilizing degreased rice bran |
08/01/2012 | CN102618608A Application of amygdalus comnnis in preparation of angiotensin converting enzyme (ACE) inhibitor |
08/01/2012 | CN102618607A Preparation method for sunflower seed oligopeptide with high F value |
08/01/2012 | CN102618606A Echinocandin biotransformation method |
08/01/2012 | CN102618605A Unnatural reactive amino acid genetic code additions |
08/01/2012 | CN102618604A Preparation method of cyclic lipopeptide compound |
08/01/2012 | CN102618565A Cytotoxic T lymphocyte-associated antigen-4, (CTLA-4) fusion protein and preparation method and application thereof |
08/01/2012 | CN102618552A Productive technology of recombined exenatide |
08/01/2012 | CN102617735A Antibodies against human IL17 and uses thereof |
08/01/2012 | CN102617733A Antibodies directed against amyloid-beta peptide and methods using same |
08/01/2012 | CN102617724A Swine alexin pBD1 polypeptide and application thereof to inhibition of swine pathogenetic fungi |
08/01/2012 | CN102617722A Ancylostoma caninum anticoagulant peptide, preparation and application thereof |
08/01/2012 | CN102617707A New homologue 2-methyl-actinomycin D of actinomycin D and its preparation method |
08/01/2012 | CN102617702A Production method of peptidoglycan |
08/01/2012 | CN102614503A Edwardsiella tarda recombinant protein vaccines, and preparation and application thereof |
08/01/2012 | CN102021125B Organic solvent resistant protease producing strain, gene of organic solvent resistant protease produced thereby and application of organic solvent resistant protease |
08/01/2012 | CN101906453B Fermentation process for preparing nisin |
08/01/2012 | CN101798576B Encoding sequence for Late Embryogenesis Abundant protein of Jatropha curcas and application in plants |
08/01/2012 | CN101272693B Process for production of fermented milk and fermented milk beverage/food |
07/31/2012 | US8232449 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies |
07/31/2012 | US8232373 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
07/31/2012 | US8232372 Engineered anti-TSLP antibody |
07/31/2012 | US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders |
07/31/2012 | US8232100 Method for producing dendritic cells |
07/31/2012 | US8232086 Method for preparing maltogenic alpha-amylase variants |
07/31/2012 | US8232083 Method of producing lycopene using recombinant Escherichia coli |
07/31/2012 | US8232080 Variant Hyprocrea jecorina CBH1 cellulases |
07/31/2012 | US8232077 Oocytes derived from ovarian culture initially containing no oocytes |
07/31/2012 | US8232076 Neurogenin |